- Home
- TARS vs EOSE Comparison
TARS vs EOSE Comparison
Compare TARS & EOSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- EOSE
- Stock Information
- Founded
- TARS 2016
- EOSE 2008
- Country
- TARS United States
- EOSE United States
- Employees
- TARS N/A
- EOSE N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- EOSE Industrial Machinery/Components
- Sector
- TARS Health Care
- EOSE Miscellaneous
- Exchange
- TARS Nasdaq
- EOSE Nasdaq
- Market Cap
- TARS 1.7B
- EOSE 2.0B
- IPO Year
- TARS 2020
- EOSE N/A
- Fundamental
- Price
- TARS $49.36
- EOSE $8.20
- Analyst Decision
- TARS Strong Buy
- EOSE Buy
- Analyst Count
- TARS 7
- EOSE 4
- Target Price
- TARS $67.14
- EOSE $7.50
- AVG Volume (30 Days)
- TARS 652.0K
- EOSE 11.6M
- Earning Date
- TARS 11-12-2025
- EOSE 11-04-2025
- Dividend Yield
- TARS N/A
- EOSE N/A
- EPS Growth
- TARS N/A
- EOSE N/A
- EPS
- TARS N/A
- EOSE N/A
- Revenue
- TARS $295,521,000.00
- EOSE $33,800,000.00
- Revenue This Year
- TARS $33,170.29
- EOSE $869.24
- Revenue Next Year
- TARS N/A
- EOSE $218.24
- P/E Ratio
- TARS N/A
- EOSE N/A
- Revenue Growth
- TARS 254.45
- EOSE 128.49
- 52 Week Low
- TARS $30.23
- EOSE $2.06
- 52 Week High
- TARS $59.76
- EOSE $8.23
- Technical
- Relative Strength Index (RSI)
- TARS 36.86
- EOSE 69.33
- Support Level
- TARS $55.45
- EOSE $6.72
- Resistance Level
- TARS $59.76
- EOSE $7.37
- Average True Range (ATR)
- TARS 2.01
- EOSE 0.59
- MACD
- TARS -1.34
- EOSE 0.04
- Stochastic Oscillator
- TARS 8.77
- EOSE 98.09
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.